### Analysis:

UnitedHealth Group reported strong Q1 2015 earnings, with revenue growth of 33% and earnings per share (EPS) of $1.46, driven by solid performance across all business units. The company's guidance for 2015 was increased, reflecting strong momentum and improved cost management. Key highlights include:

- **UnitedHealthcare**: Revenue grew 11.5% to $32.6 billion, with strong performance in commercial and Medicare segments.
- **Optum**: Revenue grew 14.7% to $12.8 billion, with operating margins stable at 5.8% despite acquisition costs.
- **Catamaran Acquisition**: The acquisition is expected to be accretive to earnings in 2016, with $0.30 per share accretion after absorbing $0.20 per share in amortization expenses.

Management expressed confidence in the company's ability to execute on its strategic initiatives, including the Catamaran acquisition, which is expected to enhance capabilities in specialty pharmacy and synchronization.

### Conclusion:

The short-term impact on UnitedHealth Group's stock is likely to be positive, given the strong earnings report and upward revision in guidance. The company's diversified business model and strategic initiatives, such as the Catamaran acquisition, suggest long-term growth prospects. The stock is expected to benefit from the positive momentum and improved cost management.

**Rating: 1**